Results
Title

Ovarian steroids and cancer: news on the breast, questions on the reproductive tract.

Authors

Hidalgo-Mora, Juan J.; Tarín, Juan J.; Cano, Antonio

Abstract

Interesting challenges ahead include uncovering the potential role of RANK/RANKL in estrogen-dependent proliferation in the endometrium, and determining whether the progestogenic effect, which limits proliferation in the endometrium, is in any way related to the RANK/RANKL system. The association between steroid hormones and cancer has been a primary research focus for many years. Reproductive hormones are of particular interest given the fact that several highly prevalent cancers in women, such as breast or endometrial cancer [[1]], are paradigmatic examples of endocrine-related cancer.

Subjects

RALOXIFENE; OVARIAN cancer; GENITALIA; OSTEOCLASTS; BREAST cancer; NF-kappa B; TUMOR necrosis factors

Publication

Gynecological Endocrinology, 2021, Vol 37, Issue 5, p383

ISSN

0951-3590

Publication type

Academic Journal

DOI

10.1080/09513590.2021.1904871